Target (CBDY) Operating Leases (2020 - 2026)

Target (CBDY) reported Operating Leases of $795392.0 for Q1 2026, down 15.93% year-over-year from $946091.0 in Q1 2025, and down 7.31% quarter-over-quarter from $858088.0 in Q4 2025.

Target (CBDY) Operating Leases (2020 - 2026) Analysis & Trends

Target (CBDY) has 7 years of Operating Leases data on file, last reported at $795392.0 in Q1 2026.

  • Operating Leases for Q1 2026 came in at $795392.0, down 15.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $795392.0 (down 15.93% YoY), and the FY2025 annual result was $858088.0, down 12.86% from the prior year.
  • Operating Leases retreated to $795392.0 in Q1 2026 per CBDY's latest filing, from $858088.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $1.6 million in Q1 2022 and troughed at $795392.0 in Q1 2026.
  • A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2022 and 2025: Operating Leases advanced 0.64% in 2022, then fell 27.72% in 2025.
  • A 5-year view of Operating Leases shows it stood at $1.3 million in 2022, then declined by 7.25% to $1.2 million in 2023, then declined by 19.55% to $984691.0 in 2024, then decreased by 12.86% to $858088.0 in 2025, then declined by 7.31% to $795392.0 in 2026.
  • Business Quant data shows CBDY's Operating Leases at $795392.0 in Q1 2026, $858088.0 in Q4 2025, and $890579.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 795,392.00
Dec 31, 2025 858,088.00
Sep 30, 2025 890,579.00
Jun 30, 2025 953,740.00
Mar 31, 2025 946,091.00
Dec 31, 2024 984,691.00
Sep 30, 2024 1.23 Mn
Jun 30, 2024 1.11 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 1.23 Mn
Jun 30, 2023 1.41 Mn
Mar 31, 2023 1.29 Mn
Dec 31, 2022 1.32 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.56 Mn
Mar 31, 2022 1.63 Mn
Dec 31, 2021 1.53 Mn
Sep 30, 2021 1.55 Mn
Jun 30, 2021 1.71 Mn